ENH split aim 2 into a and b
This commit is contained in:
parent
436eccc733
commit
5b6c4bed54
|
@ -478,9 +478,9 @@ cells compared to state-of-the-art beads using \invivo{} mouse models for
|
||||||
|
|
||||||
In Chapter~\ref{background}, we provide additional background on the current
|
In Chapter~\ref{background}, we provide additional background on the current
|
||||||
state of T cell manufacturing and how the work in this dissertation moves the
|
state of T cell manufacturing and how the work in this dissertation moves the
|
||||||
field forward. In Chapters~\ref{aim1},~\ref{aim2}, and~\ref{aim3} we present the
|
field forward. In Chapters~\ref{aim1},~\ref{aim2a},~\ref{aim2b}, and~\ref{aim3}
|
||||||
work pertaining to Aims 1, 2, and 3 respectively. Finally, we present our final
|
we present the work pertaining to Aims 1, 2, and 3 respectively. Finally, we
|
||||||
conclusions in Chapter~\ref{conclusions}.
|
present our final conclusions in Chapter~\ref{conclusions}.
|
||||||
|
|
||||||
\chapter{background and significance}\label{background}
|
\chapter{background and significance}\label{background}
|
||||||
\section*{background}
|
\section*{background}
|
||||||
|
@ -1545,7 +1545,14 @@ immunotherapies are activated and expanded with either soluble mAbs or
|
||||||
bead-immobilized mAbs, our system will likely serve as a drop-in substitution to
|
bead-immobilized mAbs, our system will likely serve as a drop-in substitution to
|
||||||
provide these benefits.
|
provide these benefits.
|
||||||
|
|
||||||
\chapter{aim 2}\label{aim2}
|
\chapter{aim 2a}\label{aim2a}
|
||||||
|
|
||||||
|
\section{introduction}
|
||||||
|
\section{methods}
|
||||||
|
\section{results}
|
||||||
|
\section{discussion}
|
||||||
|
|
||||||
|
\chapter{aim 2b}\label{aim2b}
|
||||||
|
|
||||||
\section{introduction}
|
\section{introduction}
|
||||||
\section{methods}
|
\section{methods}
|
||||||
|
|
Loading…
Reference in New Issue